CIK 0001721484 · <br>Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472174146
- Phone
- 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −10,250 | $0.59 | $6K | 228,831 |
| 2026-01-02 | Blass Devin CTO & SVP of CMC | Shares withheld for taxes | −10,700 | $0.59 | $6K | 200,176 |
| 2026-01-02 | Powell James Nathaniel Chief Executive Officer | Shares withheld for taxes | −2,464 | $0.59 | $1K | 125,593 |
| 2025-10-01 | Paletta George A. Jr. Director | Grant or award | +34,000 | 34,000 | ||
| 2025-10-01 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −11,883 | $0.74 | $9K | 226,814 |
| 2025-10-01 | Powell James Nathaniel Chief Executive Officer | Shares withheld for taxes | −2,389 | $0.74 | $2K | 128,057 |
| 2025-10-01 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −4,944 | $0.74 | $4K | 351,129 |
| 2025-10-01 | Blass Devin CTO & SVP of CMC | Shares withheld for taxes | −7,609 | $0.74 | $6K | 210,876 |
| 2025-10-01 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −11,883 | $0.74 | $9K | 239,081 |
| 2025-09-04 | Powell James Nathaniel Chief Executive Officer | Grant or award | +50,000 | 130,446 | ||
| 2025-09-04 | Powell James Nathaniel Chief Executive Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-08-11 | Locklear Lisa Chief Financial Officer | Purchase | +11,766 | 250,964 | ||
| 2025-08-11 | Locklear Lisa Chief Financial Officer | Purchase · Warrant (right to buy) | +29,415 | 29,415 | ||
| 2025-08-11 | Baluch Khoso Director | Purchase | +11,766 | 52,516 | ||
| 2025-08-11 | Baluch Khoso Director | Purchase · Warrant (right to buy) | +29,415 | 29,415 | ||
| 2025-07-15 | Hare Joshua Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +109,000 | 109,000 | ||
| 2025-07-15 | Soffer Rock Director | Grant or award | +17,000 | 226,034 | ||
| 2025-07-15 | Agafonova Nataliya Chief Medical Officer | Grant or award | +102,000 | 238,697 | ||
| 2025-07-15 | Agafonova Nataliya Chief Medical Officer | Grant or award · Stock Option (right to buy) | +34,000 | 34,000 | ||
| 2025-07-15 | Hajjar Roger Joseph Director | Grant or award | +17,000 | 33,000 |
Page 3 of 7 · 123 trades